KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+47.5%
5Y CAGR+44.3%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+47.5%/yr
vs -11.9%/yr prior
5Y CAGR
+44.3%/yr
Recent acceleration
Acceleration
+59.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
6.2x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $98.64M | +210.3% |
| 2024 | $31.79M | -43.5% |
| 2023 | $56.24M | +83.0% |
| 2022 | $30.73M | -39.3% |
| 2021 | $50.59M | +220.4% |
| 2020 | $15.79M | -50.7% |
| 2019 | $32.01M | -37.3% |
| 2018 | $51.05M | +65.0% |
| 2017 | $30.95M | +42.2% |
| 2016 | $21.76M | - |